Center for Medicine in the Public Interest
| Abbreviation | CMPI |
|---|---|
| Type | non-profit medical issues research group think tank |
| Headquarters | New York City, United States |
|
Key people
|
|
|
Revenue (2014)
|
$353,000 |
| Expenses (2014) | $373,744 |
| Website | cmpi.org |
The Center for Medicine in the Public Interest (CMPI) is a non-profit medical issues research group. It was founded by the Pacific Research Institute. CMPI's research agenda deals with clinical outcomes and econometric studies that analyze the value of new medicines and genomic and molecular-based medical innovation.
CMPI is a 501(c)3 organization and as such is not permitted to devote a substantial part of its activity to lobbying. Its officers have written articles on various issues including price controls on pharmaceutical products in publicly funded healthcare schemes in the United States, and restrictions on advertising in the European Union. The Economist Intelligence Unit has written that the organisation generally takes a pro-drug industry viewpoint.
CMMPI is a strong opponent of socialized medicine and favors a free-market approach to health care policy. The center created website called BigGovHealth.org to tell the stories of people who faced difficulties with the health care systems in Europe and Canada. The site also includes interviews with health policy experts in Europe and Canada.
CMPI was founded by Peter Pitts, former FDA Associate Commissioner for External Relations under the Bush administration, and Dr. Robert Goldberg, former fellow at the Manhattan Institute.
CMPI Senior Fellows include:
Funders include PhRMA and Pfizer.
CMPI has published studies on the value of new cancer drugs, the cost-effectiveness of certain Alzheimer's treatments, evidence-based medicine, and drug counterfeiting.
...
Wikipedia